Meissa Vaccines Expands Leadership Team as Company Advances Intranasal RSV and COVID-19 Live Attenuated Vaccine Candidates

REDWOOD CITY, Calif.--(BUSINESS WIRE)-- #COVID19--Meissa Vaccines appoints William (Bill) Daly, J.D., MBA, as Chief Business Officer and Keith H. Wells, Ph.D., as Chief Manufacturing Officer.

Click to view original post